Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
7,354,969
-
Total 13F shares
-
44,191,085
-
Share change
-
+3,840,718
-
Total reported value
-
$734,149,889
-
Put/Call ratio
-
23%
-
Price per share
-
$16.62
-
Number of holders
-
121
-
Value change
-
+$63,780,372
-
Number of buys
-
69
-
Number of sells
-
49
Institutional Holders of Kezar Life Sciences, Inc. - Common Stock, $0.001 par value (KZR) as of Q1 2022
As of 31 Mar 2022,
Kezar Life Sciences, Inc. - Common Stock, $0.001 par value (KZR) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,191,085 shares.
The largest 10 holders included
Bellevue Group AG, Avidity Partners Management LP, BlackRock Inc., FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., STATE STREET CORP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., VICTORY CAPITAL MANAGEMENT INC, and Logos Global Management LP.
This page lists
121
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.